# Serosurvey of HAV Immunity and Single-dose Vaccine Immunogenicity Among Patients With Cirrhosis

> **NCT07433881** · — · NOT_YET_RECRUITING · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 360 (estimated)

## Conditions studied

- Liver Cirrhosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07433881
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-25
- **Primary completion:** 2027-02-27
- **Final completion:** 2027-02-27
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07433881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07433881, "Serosurvey of HAV Immunity and Single-dose Vaccine Immunogenicity Among Patients With Cirrhosis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07433881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*